IRIS
MUSOLINO, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.072
EU - Europa 5.910
AS - Asia 5.000
SA - Sud America 2.258
AF - Africa 160
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.422
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.876
SG - Singapore 2.254
BR - Brasile 2.011
IE - Irlanda 1.517
CN - Cina 1.289
SE - Svezia 1.268
IT - Italia 780
HK - Hong Kong 673
DE - Germania 476
UA - Ucraina 381
VN - Vietnam 284
FI - Finlandia 279
RU - Federazione Russa 248
GB - Regno Unito 242
PL - Polonia 226
FR - Francia 137
IN - India 104
AR - Argentina 94
CA - Canada 86
MX - Messico 67
HU - Ungheria 60
BE - Belgio 56
AT - Austria 54
ZA - Sudafrica 52
EC - Ecuador 50
TR - Turchia 47
BD - Bangladesh 46
ID - Indonesia 43
ES - Italia 41
NL - Olanda 40
IQ - Iraq 33
JP - Giappone 28
MA - Marocco 28
PK - Pakistan 25
UZ - Uzbekistan 25
CO - Colombia 24
KE - Kenya 24
EG - Egitto 19
IR - Iran 19
VE - Venezuela 18
CZ - Repubblica Ceca 17
PY - Paraguay 16
AE - Emirati Arabi Uniti 14
CL - Cile 14
LT - Lituania 14
JO - Giordania 13
HN - Honduras 12
TN - Tunisia 12
AZ - Azerbaigian 11
IL - Israele 11
BO - Bolivia 10
DO - Repubblica Dominicana 10
UY - Uruguay 10
GR - Grecia 9
KG - Kirghizistan 9
RO - Romania 9
AU - Australia 8
KR - Corea 8
PE - Perù 8
BG - Bulgaria 7
LB - Libano 7
NO - Norvegia 7
AL - Albania 6
CH - Svizzera 6
DK - Danimarca 6
JM - Giamaica 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
TW - Taiwan 6
AO - Angola 5
CI - Costa d'Avorio 5
KZ - Kazakistan 5
SY - Repubblica araba siriana 5
CR - Costa Rica 4
EU - Europa 4
GE - Georgia 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AM - Armenia 3
BH - Bahrain 3
DZ - Algeria 3
RS - Serbia 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
EE - Estonia 2
GY - Guiana 2
KH - Cambogia 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
TG - Togo 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
Totale 22.402
Salva come PNG Salva come JPEG
Città #
Dublin 1.517
Chandler 1.272
Singapore 1.080
Ashburn 1.018
Dallas 1.017
Jacksonville 800
Nyköping 727
Hong Kong 673
Beijing 572
Messina 351
Princeton 279
Dearborn 268
Medford 258
Los Angeles 231
The Dalles 218
Des Moines 212
Warsaw 212
Cambridge 209
Ann Arbor 185
São Paulo 176
New York 153
Boardman 139
Munich 126
Buffalo 110
Ho Chi Minh City 89
Moscow 83
Woodbridge 77
Redondo Beach 74
Tianjin 70
Wilmington 64
Belo Horizonte 63
Rio de Janeiro 60
Budapest 59
Hanoi 57
Brussels 56
San Mateo 56
Jinan 51
Vienna 46
Turku 42
Brasília 41
Shenyang 41
Nanjing 40
Hebei 36
Lancaster 36
Houston 35
Johannesburg 34
Seattle 34
Helsinki 33
Montreal 33
Bremen 32
Porto Alegre 32
Pune 32
Brooklyn 30
Santa Clara 29
Dong Ket 27
Frankfurt am Main 27
Milan 27
Tokyo 27
Zhengzhou 27
Council Bluffs 26
Hangzhou 26
Jakarta 26
London 26
Nuremberg 26
Curitiba 25
Chennai 23
Strasbourg 23
Stockholm 22
Tashkent 22
Guarulhos 21
Nairobi 20
Ningbo 20
Poplar 20
Rome 20
Boston 19
Quito 19
Ribeirão Preto 19
San Francisco 19
Amsterdam 18
Denver 18
Düsseldorf 18
Haikou 18
Palermo 18
Recife 18
Campinas 17
Salvador 17
Atlanta 15
Chicago 15
Guangzhou 15
Norwalk 15
Washington 15
Auburn Hills 14
Falls Church 14
Toronto 14
Contagem 13
Hyderabad 13
Osasco 13
Ottawa 13
São Bernardo do Campo 13
São José dos Campos 13
Totale 14.162
Salva come PNG Salva come JPEG
Nome #
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 222
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 180
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 178
A multivariate analysis of Multiple Myeloma subtype plasma cells 176
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 161
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 155
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 150
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 148
E rosette formation in B cell chronic lymphocytic leukemia. 145
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 145
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 139
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 137
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 136
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 136
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 135
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 135
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 134
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 133
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 133
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 132
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 130
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 130
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 128
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 126
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 125
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 125
L'ipersplenismo: attualità e prospettive future 124
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 124
The cancer stem cell hypothesis: a guide to potential molecular targets. 123
Cutaneous adverse reactions to lenalidomide. 122
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 122
Phage-AgNPs complex as SERS probe for U937 cell identification 120
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 119
Anxiety, Depression, Distress, and Resilience in Patients with Haematological Malignancies. The Effect of Nine Weeks of Psychological Support on Psychological Status and Stress Biological Markers 119
Beta 2 microglobulina ed emopatie maligne 117
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 117
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 116
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 116
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 115
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 114
Serum levels of interleukin-16 in lymphoid malignancies. 114
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 114
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 114
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 114
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 113
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 112
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 112
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 111
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 111
Vaccination of multiple myeloma: Current strategies and future prospects 111
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 110
Telomerase and telomere biology in hematological diseases: A new therapeutic target 110
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 110
Role of the microbiota in hematologic malignancies. 109
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 109
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 107
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 106
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 106
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 106
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 106
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 105
Vaccination strategies in lymphoproliferative disorders: Failures and successes 105
null 105
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 104
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 102
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 101
Allergy and risk of hematologic malignancies: Associations and mechanisms. 100
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 100
Extramedullary plasmacytoma of the maxilla simulating a maxillary radicular cyst: Quick diagnosis and management 99
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 98
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 98
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 98
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 97
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 96
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 95
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 95
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 95
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 95
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 95
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 95
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 94
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 94
Cancer and sars-cov-2 infection: Diagnostic and therapeutic challenges 94
Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies 93
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 91
Global cardiovascular assessment in patients with PH+ chronic myeloid leukaemia treated with TKI: long-term follow-up 91
EVALUATION OF DECORIN AND BIGLYCAN GENE EXPRESSION IN LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA. 90
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 90
The metabolomic signature of hematologic malignancies 90
Standardisation of minimal residual disease in multiple myeloma 90
Cardiac involvement in patients with hematologic malignancies. 89
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 89
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma 89
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 88
Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction 88
Lipid profile in hematologic neoplasms 88
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 88
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 86
Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia. 86
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 86
Totale 11.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021976 0 0 0 0 0 174 36 170 133 243 120 100
2021/20221.637 16 118 24 73 54 23 101 65 54 225 222 662
2022/20234.587 409 392 215 409 312 466 53 231 1.862 27 146 65
2023/20241.087 100 197 70 85 98 247 26 71 11 27 16 139
2024/20255.537 136 85 99 337 304 143 91 1.253 1.479 316 463 831
2025/20265.492 702 1.031 1.190 1.087 1.338 144 0 0 0 0 0 0
Totale 22.853